文献

J-GLOBAL ID：201702233573801408   整理番号：17A0519139

治療抵抗性強迫神経症の患者におけるエスシタロプラムとフルボキサミンの併用療法 症例報告

Escitalopram and fluvoxamine combination therapy in a patient with treatment-resistant obsessive-compulsive disorder: a case report

著者 (16件)： Tarutani Seiichiro (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Tarutani Seiichiro (Department of Neuropsychiatry, Osaka Medical College) ,  Kikuyama Hiroki (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Kikuyama Hiroki (Department of Neuropsychiatry, Osaka Medical College) ,  Tamura Yumi (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Okayama Tatsushi (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Okayama Tatsushi (Department of Neuropsychiatry, Osaka Medical College) ,  Toyoda Katsunori (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Toyoda Katsunori (Department of Neuropsychiatry, Osaka Medical College) ,  Kanazawa Tetsufumi (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Kanazawa Tetsufumi (Department of Neuropsychiatry, Osaka Medical College) ,  Ohta Munehiro (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Yasui-Furukori Norio (Department of Neuropsychiatry, Hirosaki University School of Medicine) ,  Okamura Takehiko (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Yoneda Hiroshi (Department of Psychiatry, Shin-Abuyama Hospital, Osaka Institute of Clinical Psychiatry) ,  Yoneda Hiroshi (Department of Neuropsychiatry, Osaka Medical College)
資料名： Clinical Neuropsychopharmacology and Therapeutics (Web)  (Clinical Neuropsychopharmacology and Therapeutics (Web))
巻： 7  ページ： 36-40(J-STAGE)  発行年： 2016年 
JST資料番号： U0228A  ISSN： 1884-8826  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 選択的セロトニン再取込み阻害薬(SSRI)は強迫神経症(OC...

シソーラス用語： ヒト ,...
準シソーラス用語： CYP2C19

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0519139&from=J-GLOBAL&jstjournalNo=U0228A") }}

著者キーワード (6件)： obsessive-compulsive disorder (OCD) ,  combination therapy ,  escitalopram ,  fluvoxamine ,  drug interaction ,  CYP2C19

分類 (2件)： 向精神薬の臨床への応用  (GW03110J) ,  精神障害の薬物療法  (GR04020D)

物質索引 (2件)： エスシタロプラム ,  フルボキサミン

引用文献 (18件)：

• [1] Fineberg NA, Tonnoir B, Lemming O, Stein DJ. Escitalopram prevents relapse of obsessive-compulsive disorder. European neuropsychopharmacology: Journal of the European College of Neuropsychopharmacology. 2007;17 (6-7):430-9.
• [2] Stein DJ, Koen N, Fineberg N, Fontenelle LF, Matsunaga H, Osser D, et al. A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Current psychiatry reports. 2012;14 (3):211-9.
• [3] Ipser JC, Carey P, Dhansay Y, Fakier N, Seedat S, Stein DJ. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. The Cochrane database of systematic reviews. 2006 (4):Cd005473.
• [4] Yasui-Furukori N, Saito M, Uno T, Takahata T, Sugawara K, Tateishi T. Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes. J Clin Pharmacol. 2004;44:1223-9.
• [5] Movig KL, Leufkens HG, Belitser SV, Lenderink AW, Egberts AC. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiology and drug safety. 2002;11 (4):271-9.

タイトルに関連する用語 (7件)： 治療抵抗性 ,  強迫神経症 ,  患者 ,  エスシタロプラム ,  フルボキサミン ,  併用療法 ,  症例報告